InvestSMART

PainChek Ltd (ASX: PCK) - Announcements

Current share price for PCK : $0.078 0.008 (11.43%)+

ASX company news and announcements for PainChek Ltd (PCK) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All PainChek Ltd (PCK) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than PainChek Ltd (PCK), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for PainChek Ltd (PCK)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$16 Trading Halt 7 Oct 2025 9:23AM $0.080 $0.078 fallen by 2.50%
$16 Notification of cessation of securities - PCK 2 Oct 2025 9:51AM $0.057 $0.078 risen by 36.84%
$16 Change of Director's Interest Notice 1 Oct 2025 3:36PM $0.057 $0.078 risen by 36.84%
$16 Corporate Governance Statement and Appendix 4G 2025 30 Sep 2025 2:42PM $0.057 $0.078 risen by 36.84%
$16 Annual Report to shareholders 30 Sep 2025 2:40PM $0.057 $0.078 risen by 36.84%
$16 Application for quotation of securities - PCK 29 Sep 2025 4:30PM $0.052 $0.078 risen by 50%
$16 Change of Director's Interest Notice x3 19 Sep 2025 11:37AM $0.050 $0.078 risen by 56%
$16 Compelling Clinical and Economic Results in Scottish Pilot 17 Sep 2025 9:04AM $0.049 $0.078 risen by 59.18%
$16 Application for quotation of securities - PCK 15 Sep 2025 1:06PM $0.052 $0.078 risen by 50%
$16 Preliminary Final Report 29 Aug 2025 8:26AM $0.041 $0.078 risen by 90.24%
$16 Preliminary Final Report 29 Aug 2025 8:26AM $0.041 $0.078 risen by 90.24%
$16 Notice under Section 708A(5)(e) of the Corporations Act 2001 5 Aug 2025 9:34AM $0.035 $0.078 risen by 122.86%
$16 Application for quotation of securities - PCK 5 Aug 2025 9:25AM $0.035 $0.078 risen by 122.86%
$16 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jul 2025 8:25AM $0.038 $0.078 risen by 105.26%
$16 Quarterly update & Appendix 4C webinar 29 Jul 2025 8:23AM $0.037 $0.078 risen by 110.81%
$16 Proposed issue of securities - PCK 28 Jul 2025 9:58AM $0.040 $0.078 risen by 95%
$16 Investor Presentation 28 Jul 2025 9:58AM $0.040 $0.078 risen by 95%
$16 Strongly Supported A$7.5m Placement to Drive Int. Growth 28 Jul 2025 9:58AM $0.040 $0.078 risen by 95%
$16 Trading Halt 24 Jul 2025 9:20AM $0.040 $0.078 risen by 95%
$16 Final US FDA De Novo Clearance Submission Completed 21 Jul 2025 9:01AM $0.039 $0.078 risen by 100%
$16 Notification of cessation of securities - PCK 11 Jul 2025 1:40PM $0.041 $0.078 risen by 90.24%
$16 Change in Directors' Interest Notice x 5 7 Jul 2025 11:47AM $0.039 $0.078 risen by 100%
$16 Notification regarding unquoted securities - PCK 7 Jul 2025 11:27AM $0.039 $0.078 risen by 100%
$16 PainChek Reports Strong Quarterly Sales Growth 3 Jul 2025 9:01AM $0.044 $0.078 risen by 77.27%
$16 Application for quotation of securities - PCK 6 Jun 2025 4:01PM $0.040 $0.078 risen by 95%

76 - 100 of 485 results

Page 4 of 20

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.